Remove 2010 Remove Compounding Remove Pharmaceutical Companies
article thumbnail

The digital transformation of pharma’s physician engagement strategies

pharmaphorum

The pandemic has ushered in a number of major changes to healthcare systems, notably in the ways in which pharmaceutical companies communicate, visit and engage with physicians. The threat of disease spread and other risk factors from COVID-19 have only compounded this. Follow him on Twitter or connect with him on LinkedIn.

article thumbnail

Preventing fungal contamination in pharmaceuticals

European Pharmaceutical Review

In a review on fungal-contaminated compounded pharmaceuticals and medical devices, researchers have described how the contamination of these products can be due to breaches in sterile compounding procedures. Ahmed et al.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The role of outsourcing in antibody drug manufacture

European Pharmaceutical Review

A study investigating the trend for existing pharmaceutical companies to outsource to contracted development and manufacturing organisations (CDMOs), analysing the position of companies manufacturing monoclonal antibody drugs (mAbs). Yoshiura et al. Yoshiura et al.

article thumbnail

Speaking of Medicine – Mid-Year OPDP Enforcement Review

Eye on FDA

There are two means of gaining insight into the agency’s thinking about regulatory issues related to promotional communications by pharmaceutical companies; one is through the issuance of guidance documents, the other is through enforcement. But when it comes to enforcement things have changed greatly over the years.

article thumbnail

Innovation in small molecules: Leading companies in quinoline derivatives as anticancer agents

Pharmaceutical Technology

According to GlobalData’s Technology Foresights, which uses over 756,000 patents to analyse innovation intensity for the pharmaceutical industry, there are 110 innovation areas that will shape the future of the industry. The structure of quinoline is represented by the fusion of benzene ring with pyridine at two neighbouring carbon atoms.

article thumbnail

Innovation in chemotherapy: Leading companies in platinum-based cancer drug compositions

Pharmaceutical Technology

These compounds cause their therapeutic effect by inhibiting DNA synthesis. GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies.

article thumbnail

Digital strategies for pharma’s physician engagement

pharmaphorum

Physician access issues coupled with message delivery disconnects only compounded the problem. Florent Edouard is the global head of commercial excellence at Grünenthal Group , a pharmaceutical company headquartered in Germany and specialized in pain. When the access was actually made, the interaction was not so good.